Medication info
Tenegliptin Extended-release 20/1000 mg

Tenegliptin Extended-release 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pink oval extended-release film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202202637 · Approved 2022.06.27 · Insurance code 671707040

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to the extended-release formulation, blood glucose control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, consider reducing the sulfonylurea dose to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to this medicine from other antihyperglycemic agents. Because any change may cause changes in blood glucose control, changes in treatment for patients with type 2 diabetes should be made under close monitoring. To preserve the extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to aid blood sugar control in patients with type 2 diabetes by using Tenegliptin and Metformin together. It helps enhance blood sugar management as an adjunct for patients who are also implementing dietary control and exercise therapy.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to the extended-release formulation, blood glucose control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, consider reducing the sulfonylurea dose to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to this medicine from other antihyperglycemic agents. Because any change may cause changes in blood glucose control, changes in treatment for patients with type 2 diabetes should be made under close monitoring. To preserve the extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Precautions

This medication is used for treating diabetes and helps control blood sugar. However, there are several precautions to take when using this medication. First, it can rarely induce a condition called lactic acidosis, where lactic acid excessively accumulates in the body, leading to a dangerous state. This lactic acidosis is more likely to occur in patients with reduced kidney function, heart disease, severe infections, or dehydration. Therefore, patients with moderate or severe renal impairment, severe heart failure, liver dysfunction, or those who are pregnant or may become pregnant should not use this medication. Additionally, patients receiving iodine contrast agents used in radiological examinations should discontinue this medication 48 hours prior to the examination and should restart it only after normal kidney function is confirmed. Caution is also advised when using this medication alongside insulin or other diabetes medications as it may result in hypoglycemia. If hypoglycemic symptoms occur, consume a sugary food immediately, and if symptoms are severe, consult medical personnel. This medication may occasionally cause side effects such as dyspepsia, diarrhea, constipation, dizziness, abdominal pain, bloating, stomatitis, gastric polyps, colonic polyps, duodenal ulcers, gastroesophageal reflux disease, decreased appetite, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), and increased serum potassium levels. Especially, sudden abdominal pain, vomiting, or severe fatigue may signal acute pancreatitis or lactic acidosis and require immediate notification to medical personnel. Furthermore, long-term use of this medication can lower vitamin B12 levels, so regular blood tests are recommended. Elderly patients or those with decreased kidney function may need dosage adjustments and should have kidney function monitored regularly. Excessive alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking during treatment with this medication. Lastly, if blisters or skin rashes occur during the course of treatment, consult a physician immediately, and the use of this medication may need to be temporarily suspended during surgical procedures or severe infections.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • bowel obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid-like dermatitis
  • acute pancreatitis
  • dizziness
Show 137 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • increased amylase
  • increased lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium concentration
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision decline
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • blood sugar increase
  • elevated blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc herniation
  • intervertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stone disease
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyp
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • discomfort in the anal rectal area
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • chest discomfort
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • chest pain
  • dysuria
  • renal cyst
  • nocturia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure sore ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius to safely preserve the medication's efficacy.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.